Dune Medical Devices Raises $21M

June 26, 2014 | Dune Medical Devices, a company specializing in removing breast tumors in one swift surgery, raised $21 million. The current financing round was led by Kraft Group and Canepa Advanced Healthcare Fund. Approximately $14 million of the total investment will go directly to the company, while the remaining $7 million will be transferred to the company in October 2014. Dune Medical Devices’ product, the MarginProbe, was approved by the FDA in the beginning of 2013. It specializes in identifying if all of cancerous parts of a breast tumor have been removed in surgery in real time, during the surgery. Dune Medical Devices was founded in 2002 and is a privately held company with offices in the US and Israel.